Katharina Hopp, Ph.D.
Affiliations: | 2013 | Biochemistry and Molecular Biology | College of Medicine - Mayo Clinic |
Area:
Genetics, Molecular Biology, OncologyGoogle:
"Katharina Hopp"Parents
Sign in to add mentor| Peter C. Harris | grad student | 2013 | College of Medicine - Mayo Clinic | |
| (Genetic dissection of ciliopathy pedigrees with unusual disease presentation or unresolved etiology.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Yashchenko A, Bland SJ, Song CJ, et al. (2023) controls kidney resident macrophage heterogeneity. Frontiers in Immunology. 14: 1082078 |
| Nguyen DT, Kleczko EK, Dwivedi N, et al. (2022) The tryptophan metabolizing enzyme indoleamine 2,3-dioxygenase 1 regulates polycystic kidney disease progression. Jci Insight |
| Klawitter J, Jackson MJ, Smith PH, et al. (2022) Kynurenines in polycystic kidney disease. Journal of Nephrology |
| Meena P, Hopp K. (2022) The Enigma of Clinical Heterogeneity Among Autosomal Recessive Polycystic Kidney Disease Siblings: Genotype Versus Other Genomic or Environmental Modifier. Kidney International Reports. 7: 1453-1455 |
| Klawitter J, Sempio C, Jackson MJ, et al. (2022) Endocannabinoid System in Polycystic Kidney Disease. American Journal of Nephrology. 1-9 |
| Song C, Li Z, Ahmed UKB, et al. (2022) A Comprehensive Immune Cell Atlas of Cystic Kidney Disease Reveals the Involvement of Adaptive Immune Cells in Injury-Mediated Cyst Progression in Mice. Journal of the American Society of Nephrology : Jasn |
| Hopp K, Kleczko EK, Gitomer BY, et al. (2022) Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease. American Journal of Physiology. Renal Physiology. 322: F258-F267 |
| Arroyo J, Escobar-Zarate D, Wells HH, et al. (2021) The genetic background significantly impacts the severity of kidney cystic disease in the Pkd1 mouse model of autosomal dominant polycystic kidney disease. Kidney International |
| Atwood DJ, Brown CN, Holditch SJ, et al. (2020) The effect of trehalose on autophagy-related proteins and cyst growth in a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease. Cellular Signalling. 109760 |
| Nowak KL, Hopp K. (2020) Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Evidence and Therapeutic Potential. Clinical Journal of the American Society of Nephrology : Cjasn |